Dexacort and Zofran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dexacort (dexamethasone sodium phosphate) and Zofran (ondansetron hydrochloride). Common drug interactions include febrile neutropenia among females and duodenal ulcer haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Dexacort and Zofran. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Dexacort?

Dexacort has active ingredients of dexamethasone sodium phosphate. eHealthMe is studying from 138 Dexacort users. Check the latest studies of Dexacort.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.



On Jul, 14, 2026

15 people who take Dexacort and Zofran together, and have interactions are studied.

Dexacort and Zofran drug interactions.

What are the common drug interactions of Dexacort and Zofran, by gender? *:

female:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Klebsiella infection
  3. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  4. Dyspnoea (difficult or laboured respiration)
  5. Oedema peripheral (superficial swelling)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Pyrexia (fever)
  8. Hepatic enzyme increased
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Bacteraemia (presence of bacteria in the blood)

male:

  1. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Staphylococcal infection (an infection with staphylococcus bacteria)
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Pyrexia (fever)
  6. Arrhythmia (irregular heartbeat)
  7. General physical health deterioration (weak health status)
  8. Infection
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Procedural site reaction

What are the common drug interactions of Dexacort and Zofran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Oedema peripheral (superficial swelling)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pyrexia (fever)

50-59:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Arrhythmia (irregular heartbeat)
  3. Chest pressure sensation (feeling of pressure on chest)
  4. Infection
  5. Procedural site reaction
  6. Pulsus bigeminus (groups of two heartbeats close together followed by a longer pause)
  7. Pyrexia (fever)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

  1. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Laboratory test abnormal
  4. Platelet count decreased
  5. Pyrexia (fever)
  6. Klebsiella infection
  7. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Hepatic enzyme increased
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Pain: 5 people, 33.33%
  2. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 26.67%
  3. Diarrhea: 3 people, 20.00%
  4. Nausea And Vomiting: 3 people, 20.00%
  5. Anaemia (lack of blood): 3 people, 20.00%
  6. Kidney Stones: 3 people, 20.00%
  7. Blood Creatinine Increased: 3 people, 20.00%
  8. Indigestion: 3 people, 20.00%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
  10. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dexacort and Zofran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dexacort and Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dexacort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zofran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dexacort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zofran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone sodium phosphate and ondansetron hydrochloride (the active ingredients of Dexacort and Zofran, respectively), and Dexacort and Zofran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: